Navigation Links
MMR Vaccine May Be A Reason Behind Autistic Children, Study Finds

Dr Andrew Wakefield, finds firstly that MMR vaccine was found to cause some autistic cases in children. Followed by him, others findings now supports// it saying (measles has been found in the intestines of children with a form of autism).

Dr Stephen Walker, of Wake Forest University Medical Centre in North Carolina, also finds a close relationship between autistic children with bowel disease and measles virus and has no verification to prove it.

A London GP and childhood vaccination expert, Richard Halvorsen, puts that the findings were sufficiently significant to prove its causation.

In the International Meeting for Autism Research in Montreal, Dr Walker presented his initial findings with 275 American children, whom suffer from sudden motor skill loses.

About 85% showed vaccine strain of measles virus in gut tissue biopsy and 35% showed a positive DNA test.

'In an effort to maintain vaccine uptake and protect susceptible children against autism I believe that the Government should, at the very least, make single vaccines available again.'

Dr Stephen Walker, also says that Government should reinstate the use of single vaccines immediately.

Since control groups were not being used in the last research, the Department of Health says it had no validity.

In contrast to the study, some spokesman and studies fails to find measles virus persisting in the blood cells of autistic children.

He added that no epidemiological or virological studies to eventually prove MMR playing a part in causing autism. WHO also recommends MMR vaccine as the best to protect against measles, mumps and rubella virus.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: